As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...
While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in ...
Spread the loveIn a groundbreaking development that has electrified the medical community, researchers have announced the ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...
Spread the loveA new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to ...
Hopes for millions of people with Alzheimer's could be on the horizon after a new drug that slows down the progression of the ...
Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...
China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...
Time with a loved one diagnosed with Alzheimer's disease is precious, and a new treatment now offered at IU Health Arnett ...
A new report from the National Academies of Sciences, Engineering, and Medicine identified fundamental changes in how ...
Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...